AEON Biopharma, Inc. (AEON)
0.1603
0.00 (0.00%)
USD |
NYAM |
Nov 06, 10:31
AEON Biopharma Total Assets (Quarterly) : 5.91M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 5.91M |
| March 31, 2026 | 8.63M |
| December 31, 2025 | 5.56M |
| September 30, 2025 | 8.734M |
| June 30, 2025 | 11.66M |
| March 31, 2025 | 13.80M |
| December 31, 2024 | 3.142M |
| September 30, 2024 | 4.004M |
| June 30, 2024 | 5.734M |
| March 31, 2024 | 3.032M |
| December 31, 2023 | 67.56M |
| September 30, 2023 | 78.33M |
| Date | Value |
|---|---|
| June 30, 2023 | 21.79M |
| March 31, 2023 | 21.62M |
| December 31, 2022 | 10.78M |
| September 30, 2022 | 277.32M |
| June 30, 2022 | 276.51M |
| March 31, 2022 | 276.65M |
| December 31, 2021 | 276.95M |
| September 30, 2021 | 277.20M |
| June 30, 2021 | 277.62M |
| March 31, 2021 | 278.15M |
| December 31, 2020 | 0.081M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.794B |
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| Anika Therapeutics, Inc. | 183.47M |
| Savara, Inc. | 192.14M |
| Vericel Corp. | 502.87M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 21.27M |
| Shareholders Equity (Quarterly) | -15.36M |
| Debt to Equity Ratio | -0.1807 |
| Current Ratio | 0.5439 |
| Net Debt Paydown Yield | 12.50% |